Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Content
    • Current
    • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Phosphorylated GSK3β-ser9 and EGFR are Good Prognostic Factors for Lung Carcinomas

HUACHUAN ZHENG, HIROSHI SAITO, SHINJI MASUDA, XIANGHONG YANG and YASUO TAKANO
Anticancer Research September 2007, 27 (5B) 3561-3569;
HUACHUAN ZHENG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: zheng_huachuan@hotmail.com
HIROSHI SAITO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHINJI MASUDA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
XIANGHONG YANG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUO TAKANO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 27 no. 5B 3561-3569
PubMed 
17972518

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received April 2, 2007
  • Revision received June 1, 2007
  • Accepted June 14, 2007
  • Published online September 1, 2007.

Copyright & Usage 
Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. HUACHUAN ZHENG1,3,
  2. HIROSHI SAITO2,
  3. SHINJI MASUDA2,
  4. XIANGHONG YANG3 and
  5. YASUO TAKANO1
  1. 1Department of Diagnostic Pathology, Graduate School of Medicine and Pharmaceutical Science, University of Toyama, Toyama
  2. 2Kouseiren Takaoka Hospital, Takaoka, Japan
  3. 3China Medical University, Shenyang, China
  1. Correspondence to: Huachuan Zheng, Department of Diagnostic Pathology, Graduate School of Medicine and Pharmaceutical Science, University of Toyama, Sugitani 2630, Toyama, Japan. Tel: +81 76 4347236, Fax: +81 76 4345016, e-mail: zheng_huachuan{at}hotmail.com

Cited By...

  • 45 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Anticancer Research: 27 (5B)
Anticancer Research
Vol. 27, Issue 5B
September-October 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Phosphorylated GSK3β-ser9 and EGFR are Good Prognostic Factors for Lung Carcinomas
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Phosphorylated GSK3β-ser9 and EGFR are Good Prognostic Factors for Lung Carcinomas
HUACHUAN ZHENG, HIROSHI SAITO, SHINJI MASUDA, XIANGHONG YANG, YASUO TAKANO
Anticancer Research Sep 2007, 27 (5B) 3561-3569;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Phosphorylated GSK3β-ser9 and EGFR are Good Prognostic Factors for Lung Carcinomas
HUACHUAN ZHENG, HIROSHI SAITO, SHINJI MASUDA, XIANGHONG YANG, YASUO TAKANO
Anticancer Research Sep 2007, 27 (5B) 3561-3569;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Gigantol Targets MYC for Ubiquitin-proteasomal Degradation and Suppresses Lung Cancer Cell Growth
  • In Vitro and In Vivo Antitumor and Anti-Inflammatory Capabilities of the Novel GSK3 and CDK9 Inhibitor ABC1183
  • Google Scholar

More in this TOC Section

  • The Evaluation of the Malignant Characteristics of Conjunctival Lesions Based on the Dermatoscopic Algorithm
  • Serological Biomarker Test (GastroPanel®) in the Diagnosis of Functional Gastric Disorders, Helicobacter pylori and Atrophic Gastritis in Patients Examined for Dyspeptic Symptoms
  • Potential Risk Factors Influencing the Formation of Postoperative Seroma After Breast Surgery – A Prospective Study
Show more Clinical Studies

Similar Articles

Anticancer Research

© 2021 Anticancer Research

Powered by HighWire